The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4

H. L.Y. Chan, C. J. Chen, O. Omede, J. Al Qamish, K. Al Naamani, A. Bane, S. S. Tan, M. Simonova, I. Cardenas, M. Derbala, O. Akin, R. O. Phillips, M. K. Abdelmageed, M. Abdulla, D. Adda, A. Al Baqali, N. Al Dweik, K. Al Ejji, I. Al ghazzawi, S. Al KaabiM. Al Sadadi, J. Al Salman, M. AlBadri, S. A. Al-Busafi, H. E. Al-Romaihi, W. Ampofo, K. Antonov, C. Anyaike, F. Arome, S. Blach, M. M. Borodo, S. M. Brandon, B. Bright, M. T. Butt, D. S. Chen, P. J. Chen, R. N. Chien, W. L. Chuang, D. Cuellar, A. A. Elbardiny, C. Estes, E. Farag, J. Fung, I. Gamkrelidze, V. Garcia, J. Genov, Z. Ghandour, M. Ghuloom, B. Gomez, J. Gunter, J. Habeeb, O. Hajelssedig, W. Hamoudi, S. M. Himatt, I. Hrstic, C. C. Hu, C. F. Huang, Y. T. Hui, R. Jahis, D. Jelev, A. K. John, K. S. Kaliaskarova, Y. Kamel, J. H. Kao, J. Khamis, H. Khattabi, I. Khoudri, A. Konysbekova, I. Kotzev, M. S. Lai, W. C. Lao, J. Layden, M. H. Lee, O. Lesi, M. Li, A. Lo, C. K. Loo, B. Lukšić, A. Maaroufi, A. O. Malu, L. Mateva, R. Mitova, R. Mohamed, M. Morović, K. Murphy, B. Mustapha, A. Nersesov, E. Ngige, R. Njouom, O. Njoya, D. Nonković, S. Obekpa, S. Oguche, E. E. Okolo, C. Omuemu, P. Ondoa, O. Opare-Sem, S. Owusu-Ofori, Y. N. Prokopenko, H. Razavi, D. Razavi-Shearer, K. Razavi-Shearer, B. Redae, T. Reic, T. Rinke de Wit, C. Rios, S. Robbins, L. R. Roberts, S. J. Sanad, J. D. Schmelzer, M. Sharma, T. H. Su, K. Sultan, K. Tchernev, O. T.Y. Tsang, S. Tsang, C. Tzeuton, S. Ugoeze, B. Uzochukwu, R. Vi, A. Vince, H. U. Wani, V. W.S. Wong, A. Workneh, R. Yacoub, K. I. Yesmembetov, M. Youbi, M. F. Yuen, H. Nde

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Qatar and Taiwan) to quantify and characterize the viremic population as well as forecast the changes in the infected population and the corresponding disease burden from 2015 to 2030. Model inputs were agreed upon through expert consensus, and a standardized methodology was followed to allow for comparison across countries. The viremic prevalence is expected to remain constant or decline in all but four countries (Ethiopia, Ghana, Jordan and Oman); however, HCV-related morbidity and mortality will increase in all countries except Qatar and Taiwan. In Qatar, the high-treatment rate will contribute to a reduction in total cases and HCV-related morbidity by 2030. In the remaining countries, however, the current treatment paradigm will be insufficient to achieve large reductions in HCV-related morbidity and mortality.

Original languageEnglish
Pages (from-to)25-43
Number of pages19
JournalJournal of Viral Hepatitis
Volume24
DOIs
Publication statusPublished - Oct 1 2017

Fingerprint

Qatar
Virus Diseases
Hepacivirus
Morbidity
Jordan
Ghana
Ethiopia
Taiwan
Mortality
Bahrain
Dominican Republic
Kazakhstan
Oman
Morocco
Bulgaria
Cameroon
Croatia
Colombia
Malaysia
Hong Kong

Keywords

  • diagnosis
  • disease burden
  • epidemiology
  • HCV
  • hepatitis C
  • incidence
  • mortality
  • prevalence
  • treatment

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases
  • Virology

Cite this

Chan, H. L. Y., Chen, C. J., Omede, O., Al Qamish, J., Al Naamani, K., Bane, A., ... Nde, H. (2017). The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4. Journal of Viral Hepatitis, 24, 25-43. https://doi.org/10.1111/jvh.12760

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm : Volume 4. / Chan, H. L.Y.; Chen, C. J.; Omede, O.; Al Qamish, J.; Al Naamani, K.; Bane, A.; Tan, S. S.; Simonova, M.; Cardenas, I.; Derbala, M.; Akin, O.; Phillips, R. O.; Abdelmageed, M. K.; Abdulla, M.; Adda, D.; Al Baqali, A.; Al Dweik, N.; Al Ejji, K.; Al ghazzawi, I.; Al Kaabi, S.; Al Sadadi, M.; Al Salman, J.; AlBadri, M.; Al-Busafi, S. A.; Al-Romaihi, H. E.; Ampofo, W.; Antonov, K.; Anyaike, C.; Arome, F.; Blach, S.; Borodo, M. M.; Brandon, S. M.; Bright, B.; Butt, M. T.; Chen, D. S.; Chen, P. J.; Chien, R. N.; Chuang, W. L.; Cuellar, D.; Elbardiny, A. A.; Estes, C.; Farag, E.; Fung, J.; Gamkrelidze, I.; Garcia, V.; Genov, J.; Ghandour, Z.; Ghuloom, M.; Gomez, B.; Gunter, J.; Habeeb, J.; Hajelssedig, O.; Hamoudi, W.; Himatt, S. M.; Hrstic, I.; Hu, C. C.; Huang, C. F.; Hui, Y. T.; Jahis, R.; Jelev, D.; John, A. K.; Kaliaskarova, K. S.; Kamel, Y.; Kao, J. H.; Khamis, J.; Khattabi, H.; Khoudri, I.; Konysbekova, A.; Kotzev, I.; Lai, M. S.; Lao, W. C.; Layden, J.; Lee, M. H.; Lesi, O.; Li, M.; Lo, A.; Loo, C. K.; Lukšić, B.; Maaroufi, A.; Malu, A. O.; Mateva, L.; Mitova, R.; Mohamed, R.; Morović, M.; Murphy, K.; Mustapha, B.; Nersesov, A.; Ngige, E.; Njouom, R.; Njoya, O.; Nonković, D.; Obekpa, S.; Oguche, S.; Okolo, E. E.; Omuemu, C.; Ondoa, P.; Opare-Sem, O.; Owusu-Ofori, S.; Prokopenko, Y. N.; Razavi, H.; Razavi-Shearer, D.; Razavi-Shearer, K.; Redae, B.; Reic, T.; Rinke de Wit, T.; Rios, C.; Robbins, S.; Roberts, L. R.; Sanad, S. J.; Schmelzer, J. D.; Sharma, M.; Su, T. H.; Sultan, K.; Tchernev, K.; Tsang, O. T.Y.; Tsang, S.; Tzeuton, C.; Ugoeze, S.; Uzochukwu, B.; Vi, R.; Vince, A.; Wani, H. U.; Wong, V. W.S.; Workneh, A.; Yacoub, R.; Yesmembetov, K. I.; Youbi, M.; Yuen, M. F.; Nde, H.

In: Journal of Viral Hepatitis, Vol. 24, 01.10.2017, p. 25-43.

Research output: Contribution to journalArticle

Chan, HLY, Chen, CJ, Omede, O, Al Qamish, J, Al Naamani, K, Bane, A, Tan, SS, Simonova, M, Cardenas, I, Derbala, M, Akin, O, Phillips, RO, Abdelmageed, MK, Abdulla, M, Adda, D, Al Baqali, A, Al Dweik, N, Al Ejji, K, Al ghazzawi, I, Al Kaabi, S, Al Sadadi, M, Al Salman, J, AlBadri, M, Al-Busafi, SA, Al-Romaihi, HE, Ampofo, W, Antonov, K, Anyaike, C, Arome, F, Blach, S, Borodo, MM, Brandon, SM, Bright, B, Butt, MT, Chen, DS, Chen, PJ, Chien, RN, Chuang, WL, Cuellar, D, Elbardiny, AA, Estes, C, Farag, E, Fung, J, Gamkrelidze, I, Garcia, V, Genov, J, Ghandour, Z, Ghuloom, M, Gomez, B, Gunter, J, Habeeb, J, Hajelssedig, O, Hamoudi, W, Himatt, SM, Hrstic, I, Hu, CC, Huang, CF, Hui, YT, Jahis, R, Jelev, D, John, AK, Kaliaskarova, KS, Kamel, Y, Kao, JH, Khamis, J, Khattabi, H, Khoudri, I, Konysbekova, A, Kotzev, I, Lai, MS, Lao, WC, Layden, J, Lee, MH, Lesi, O, Li, M, Lo, A, Loo, CK, Lukšić, B, Maaroufi, A, Malu, AO, Mateva, L, Mitova, R, Mohamed, R, Morović, M, Murphy, K, Mustapha, B, Nersesov, A, Ngige, E, Njouom, R, Njoya, O, Nonković, D, Obekpa, S, Oguche, S, Okolo, EE, Omuemu, C, Ondoa, P, Opare-Sem, O, Owusu-Ofori, S, Prokopenko, YN, Razavi, H, Razavi-Shearer, D, Razavi-Shearer, K, Redae, B, Reic, T, Rinke de Wit, T, Rios, C, Robbins, S, Roberts, LR, Sanad, SJ, Schmelzer, JD, Sharma, M, Su, TH, Sultan, K, Tchernev, K, Tsang, OTY, Tsang, S, Tzeuton, C, Ugoeze, S, Uzochukwu, B, Vi, R, Vince, A, Wani, HU, Wong, VWS, Workneh, A, Yacoub, R, Yesmembetov, KI, Youbi, M, Yuen, MF & Nde, H 2017, 'The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4', Journal of Viral Hepatitis, vol. 24, pp. 25-43. https://doi.org/10.1111/jvh.12760
Chan, H. L.Y. ; Chen, C. J. ; Omede, O. ; Al Qamish, J. ; Al Naamani, K. ; Bane, A. ; Tan, S. S. ; Simonova, M. ; Cardenas, I. ; Derbala, M. ; Akin, O. ; Phillips, R. O. ; Abdelmageed, M. K. ; Abdulla, M. ; Adda, D. ; Al Baqali, A. ; Al Dweik, N. ; Al Ejji, K. ; Al ghazzawi, I. ; Al Kaabi, S. ; Al Sadadi, M. ; Al Salman, J. ; AlBadri, M. ; Al-Busafi, S. A. ; Al-Romaihi, H. E. ; Ampofo, W. ; Antonov, K. ; Anyaike, C. ; Arome, F. ; Blach, S. ; Borodo, M. M. ; Brandon, S. M. ; Bright, B. ; Butt, M. T. ; Chen, D. S. ; Chen, P. J. ; Chien, R. N. ; Chuang, W. L. ; Cuellar, D. ; Elbardiny, A. A. ; Estes, C. ; Farag, E. ; Fung, J. ; Gamkrelidze, I. ; Garcia, V. ; Genov, J. ; Ghandour, Z. ; Ghuloom, M. ; Gomez, B. ; Gunter, J. ; Habeeb, J. ; Hajelssedig, O. ; Hamoudi, W. ; Himatt, S. M. ; Hrstic, I. ; Hu, C. C. ; Huang, C. F. ; Hui, Y. T. ; Jahis, R. ; Jelev, D. ; John, A. K. ; Kaliaskarova, K. S. ; Kamel, Y. ; Kao, J. H. ; Khamis, J. ; Khattabi, H. ; Khoudri, I. ; Konysbekova, A. ; Kotzev, I. ; Lai, M. S. ; Lao, W. C. ; Layden, J. ; Lee, M. H. ; Lesi, O. ; Li, M. ; Lo, A. ; Loo, C. K. ; Lukšić, B. ; Maaroufi, A. ; Malu, A. O. ; Mateva, L. ; Mitova, R. ; Mohamed, R. ; Morović, M. ; Murphy, K. ; Mustapha, B. ; Nersesov, A. ; Ngige, E. ; Njouom, R. ; Njoya, O. ; Nonković, D. ; Obekpa, S. ; Oguche, S. ; Okolo, E. E. ; Omuemu, C. ; Ondoa, P. ; Opare-Sem, O. ; Owusu-Ofori, S. ; Prokopenko, Y. N. ; Razavi, H. ; Razavi-Shearer, D. ; Razavi-Shearer, K. ; Redae, B. ; Reic, T. ; Rinke de Wit, T. ; Rios, C. ; Robbins, S. ; Roberts, L. R. ; Sanad, S. J. ; Schmelzer, J. D. ; Sharma, M. ; Su, T. H. ; Sultan, K. ; Tchernev, K. ; Tsang, O. T.Y. ; Tsang, S. ; Tzeuton, C. ; Ugoeze, S. ; Uzochukwu, B. ; Vi, R. ; Vince, A. ; Wani, H. U. ; Wong, V. W.S. ; Workneh, A. ; Yacoub, R. ; Yesmembetov, K. I. ; Youbi, M. ; Yuen, M. F. ; Nde, H. / The present and future disease burden of hepatitis C virus infections with today's treatment paradigm : Volume 4. In: Journal of Viral Hepatitis. 2017 ; Vol. 24. pp. 25-43.
@article{5158c39a9b9e44bea6816ed67c78a9db,
title = "The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4",
abstract = "Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Qatar and Taiwan) to quantify and characterize the viremic population as well as forecast the changes in the infected population and the corresponding disease burden from 2015 to 2030. Model inputs were agreed upon through expert consensus, and a standardized methodology was followed to allow for comparison across countries. The viremic prevalence is expected to remain constant or decline in all but four countries (Ethiopia, Ghana, Jordan and Oman); however, HCV-related morbidity and mortality will increase in all countries except Qatar and Taiwan. In Qatar, the high-treatment rate will contribute to a reduction in total cases and HCV-related morbidity by 2030. In the remaining countries, however, the current treatment paradigm will be insufficient to achieve large reductions in HCV-related morbidity and mortality.",
keywords = "diagnosis, disease burden, epidemiology, HCV, hepatitis C, incidence, mortality, prevalence, treatment",
author = "Chan, {H. L.Y.} and Chen, {C. J.} and O. Omede and {Al Qamish}, J. and {Al Naamani}, K. and A. Bane and Tan, {S. S.} and M. Simonova and I. Cardenas and M. Derbala and O. Akin and Phillips, {R. O.} and Abdelmageed, {M. K.} and M. Abdulla and D. Adda and {Al Baqali}, A. and {Al Dweik}, N. and {Al Ejji}, K. and {Al ghazzawi}, I. and {Al Kaabi}, S. and {Al Sadadi}, M. and {Al Salman}, J. and M. AlBadri and Al-Busafi, {S. A.} and Al-Romaihi, {H. E.} and W. Ampofo and K. Antonov and C. Anyaike and F. Arome and S. Blach and Borodo, {M. M.} and Brandon, {S. M.} and B. Bright and Butt, {M. T.} and Chen, {D. S.} and Chen, {P. J.} and Chien, {R. N.} and Chuang, {W. L.} and D. Cuellar and Elbardiny, {A. A.} and C. Estes and E. Farag and J. Fung and I. Gamkrelidze and V. Garcia and J. Genov and Z. Ghandour and M. Ghuloom and B. Gomez and J. Gunter and J. Habeeb and O. Hajelssedig and W. Hamoudi and Himatt, {S. M.} and I. Hrstic and Hu, {C. C.} and Huang, {C. F.} and Hui, {Y. T.} and R. Jahis and D. Jelev and John, {A. K.} and Kaliaskarova, {K. S.} and Y. Kamel and Kao, {J. H.} and J. Khamis and H. Khattabi and I. Khoudri and A. Konysbekova and I. Kotzev and Lai, {M. S.} and Lao, {W. C.} and J. Layden and Lee, {M. H.} and O. Lesi and M. Li and A. Lo and Loo, {C. K.} and B. Lukšić and A. Maaroufi and Malu, {A. O.} and L. Mateva and R. Mitova and R. Mohamed and M. Morović and K. Murphy and B. Mustapha and A. Nersesov and E. Ngige and R. Njouom and O. Njoya and D. Nonković and S. Obekpa and S. Oguche and Okolo, {E. E.} and C. Omuemu and P. Ondoa and O. Opare-Sem and S. Owusu-Ofori and Prokopenko, {Y. N.} and H. Razavi and D. Razavi-Shearer and K. Razavi-Shearer and B. Redae and T. Reic and {Rinke de Wit}, T. and C. Rios and S. Robbins and Roberts, {L. R.} and Sanad, {S. J.} and Schmelzer, {J. D.} and M. Sharma and Su, {T. H.} and K. Sultan and K. Tchernev and Tsang, {O. T.Y.} and S. Tsang and C. Tzeuton and S. Ugoeze and B. Uzochukwu and R. Vi and A. Vince and Wani, {H. U.} and Wong, {V. W.S.} and A. Workneh and R. Yacoub and Yesmembetov, {K. I.} and M. Youbi and Yuen, {M. F.} and H. Nde",
year = "2017",
month = "10",
day = "1",
doi = "10.1111/jvh.12760",
language = "English",
volume = "24",
pages = "25--43",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The present and future disease burden of hepatitis C virus infections with today's treatment paradigm

T2 - Volume 4

AU - Chan, H. L.Y.

AU - Chen, C. J.

AU - Omede, O.

AU - Al Qamish, J.

AU - Al Naamani, K.

AU - Bane, A.

AU - Tan, S. S.

AU - Simonova, M.

AU - Cardenas, I.

AU - Derbala, M.

AU - Akin, O.

AU - Phillips, R. O.

AU - Abdelmageed, M. K.

AU - Abdulla, M.

AU - Adda, D.

AU - Al Baqali, A.

AU - Al Dweik, N.

AU - Al Ejji, K.

AU - Al ghazzawi, I.

AU - Al Kaabi, S.

AU - Al Sadadi, M.

AU - Al Salman, J.

AU - AlBadri, M.

AU - Al-Busafi, S. A.

AU - Al-Romaihi, H. E.

AU - Ampofo, W.

AU - Antonov, K.

AU - Anyaike, C.

AU - Arome, F.

AU - Blach, S.

AU - Borodo, M. M.

AU - Brandon, S. M.

AU - Bright, B.

AU - Butt, M. T.

AU - Chen, D. S.

AU - Chen, P. J.

AU - Chien, R. N.

AU - Chuang, W. L.

AU - Cuellar, D.

AU - Elbardiny, A. A.

AU - Estes, C.

AU - Farag, E.

AU - Fung, J.

AU - Gamkrelidze, I.

AU - Garcia, V.

AU - Genov, J.

AU - Ghandour, Z.

AU - Ghuloom, M.

AU - Gomez, B.

AU - Gunter, J.

AU - Habeeb, J.

AU - Hajelssedig, O.

AU - Hamoudi, W.

AU - Himatt, S. M.

AU - Hrstic, I.

AU - Hu, C. C.

AU - Huang, C. F.

AU - Hui, Y. T.

AU - Jahis, R.

AU - Jelev, D.

AU - John, A. K.

AU - Kaliaskarova, K. S.

AU - Kamel, Y.

AU - Kao, J. H.

AU - Khamis, J.

AU - Khattabi, H.

AU - Khoudri, I.

AU - Konysbekova, A.

AU - Kotzev, I.

AU - Lai, M. S.

AU - Lao, W. C.

AU - Layden, J.

AU - Lee, M. H.

AU - Lesi, O.

AU - Li, M.

AU - Lo, A.

AU - Loo, C. K.

AU - Lukšić, B.

AU - Maaroufi, A.

AU - Malu, A. O.

AU - Mateva, L.

AU - Mitova, R.

AU - Mohamed, R.

AU - Morović, M.

AU - Murphy, K.

AU - Mustapha, B.

AU - Nersesov, A.

AU - Ngige, E.

AU - Njouom, R.

AU - Njoya, O.

AU - Nonković, D.

AU - Obekpa, S.

AU - Oguche, S.

AU - Okolo, E. E.

AU - Omuemu, C.

AU - Ondoa, P.

AU - Opare-Sem, O.

AU - Owusu-Ofori, S.

AU - Prokopenko, Y. N.

AU - Razavi, H.

AU - Razavi-Shearer, D.

AU - Razavi-Shearer, K.

AU - Redae, B.

AU - Reic, T.

AU - Rinke de Wit, T.

AU - Rios, C.

AU - Robbins, S.

AU - Roberts, L. R.

AU - Sanad, S. J.

AU - Schmelzer, J. D.

AU - Sharma, M.

AU - Su, T. H.

AU - Sultan, K.

AU - Tchernev, K.

AU - Tsang, O. T.Y.

AU - Tsang, S.

AU - Tzeuton, C.

AU - Ugoeze, S.

AU - Uzochukwu, B.

AU - Vi, R.

AU - Vince, A.

AU - Wani, H. U.

AU - Wong, V. W.S.

AU - Workneh, A.

AU - Yacoub, R.

AU - Yesmembetov, K. I.

AU - Youbi, M.

AU - Yuen, M. F.

AU - Nde, H.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Qatar and Taiwan) to quantify and characterize the viremic population as well as forecast the changes in the infected population and the corresponding disease burden from 2015 to 2030. Model inputs were agreed upon through expert consensus, and a standardized methodology was followed to allow for comparison across countries. The viremic prevalence is expected to remain constant or decline in all but four countries (Ethiopia, Ghana, Jordan and Oman); however, HCV-related morbidity and mortality will increase in all countries except Qatar and Taiwan. In Qatar, the high-treatment rate will contribute to a reduction in total cases and HCV-related morbidity by 2030. In the remaining countries, however, the current treatment paradigm will be insufficient to achieve large reductions in HCV-related morbidity and mortality.

AB - Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Qatar and Taiwan) to quantify and characterize the viremic population as well as forecast the changes in the infected population and the corresponding disease burden from 2015 to 2030. Model inputs were agreed upon through expert consensus, and a standardized methodology was followed to allow for comparison across countries. The viremic prevalence is expected to remain constant or decline in all but four countries (Ethiopia, Ghana, Jordan and Oman); however, HCV-related morbidity and mortality will increase in all countries except Qatar and Taiwan. In Qatar, the high-treatment rate will contribute to a reduction in total cases and HCV-related morbidity by 2030. In the remaining countries, however, the current treatment paradigm will be insufficient to achieve large reductions in HCV-related morbidity and mortality.

KW - diagnosis

KW - disease burden

KW - epidemiology

KW - HCV

KW - hepatitis C

KW - incidence

KW - mortality

KW - prevalence

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85032955067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032955067&partnerID=8YFLogxK

U2 - 10.1111/jvh.12760

DO - 10.1111/jvh.12760

M3 - Article

AN - SCOPUS:85032955067

VL - 24

SP - 25

EP - 43

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1352-0504

ER -